
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC
Kun Li, Yihang Gong, Dongbo Qiu, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 8, pp. e004006-e004006
Open Access | Times Cited: 28
Kun Li, Yihang Gong, Dongbo Qiu, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 8, pp. e004006-e004006
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Hypoxia signaling in cancer: Implications for therapeutic interventions
Yan Zhuang, Kua Liu, Qinyu He, et al.
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 50
Yan Zhuang, Kua Liu, Qinyu He, et al.
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 50
Tumor Microenvironment‐Responsive Nanoparticles Amplifying STING Signaling Pathway for Cancer Immunotherapy
Dan Liu, Shuang Liang, Kongshuo Ma, et al.
Advanced Materials (2023) Vol. 36, Iss. 6
Closed Access | Times Cited: 48
Dan Liu, Shuang Liang, Kongshuo Ma, et al.
Advanced Materials (2023) Vol. 36, Iss. 6
Closed Access | Times Cited: 48
Regulatory T cells in immune checkpoint blockade antitumor therapy
An Zhang, Tao Fan, Yixiao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
An Zhang, Tao Fan, Yixiao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment
Zhenyun Yang, Xin Wang, Yizhen Fu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Zhenyun Yang, Xin Wang, Yizhen Fu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
m5C methylation modification may be an accomplice in colorectal cancer escaping from anti-tumor effects of innate immunity-type I/III interferon
Yiqi Sun, Yunfei Liu, Lu Jiang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Yiqi Sun, Yunfei Liu, Lu Jiang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Dimethyl fumarate alleviate hepatic ischemia–reperfusion injury through suppressing cGAS‐STING signaling
Yi Xiong, Jiawen Chen, Kun Li, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
Yi Xiong, Jiawen Chen, Kun Li, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
Targeting cGAS-STING: modulating the immune landscape of hepatic diseases
Xue Feng, Yongkang Liu, Xiaoying Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Xue Feng, Yongkang Liu, Xiaoying Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Nanotechnological strategies to increase the oxygen content of the tumor
Junjie Zhang, Kaiyuan Tang, Runqi Fang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Junjie Zhang, Kaiyuan Tang, Runqi Fang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Nose to brain delivery of naringin-loaded chitosan nanoparticles for potential use in oxaliplatin-induced chemobrain in rats: impact on oxidative stress, cGAS/STING and HMGB1/RAGE/TLR2/MYD88 inflammatory axes
Diana M. F. Hanna, John Youshia, Sarah Fahmy, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 12, pp. 1859-1873
Open Access | Times Cited: 12
Diana M. F. Hanna, John Youshia, Sarah Fahmy, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 12, pp. 1859-1873
Open Access | Times Cited: 12
The dual function of cGAS-STING signaling axis in liver diseases
Xiaojiaoyang Li, Jiaorong Qu, Yin-hao Zhang, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 6, pp. 1115-1129
Closed Access | Times Cited: 4
Xiaojiaoyang Li, Jiaorong Qu, Yin-hao Zhang, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 6, pp. 1115-1129
Closed Access | Times Cited: 4
Engineered Oxygen Factories Synergize with STING Agonist to Remodel Tumor Microenvironment for Cancer Immunotherapy
Xiangkai Zhang, Yangzi Yang, Jiaxin Li, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 41
Closed Access | Times Cited: 10
Xiangkai Zhang, Yangzi Yang, Jiaxin Li, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 41
Closed Access | Times Cited: 10
Dynamic surveillance of lymphocyte subsets in patients with non-small cell lung cancer during chemotherapy or combination immunotherapy for early prediction of efficacy
Shan-Shan Zhen, Wenqian Wang, Guohui Qin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Shan-Shan Zhen, Wenqian Wang, Guohui Qin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Targeting EMT using low-dose Teniposide by downregulating ZEB2-driven activation of RNA polymerase I in breast cancer
Brandon J. Metge, Heba Allah Alsheikh, Sarah C. Kammerud, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 2
Brandon J. Metge, Heba Allah Alsheikh, Sarah C. Kammerud, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 2
RNA m5C methylation: a potential modulator of innate immune pathways in hepatocellular carcinoma
Sun Meng, Bai Jiangtao, Wang Haisong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Sun Meng, Bai Jiangtao, Wang Haisong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
GAS-STING: a classical DNA recognition pathways to tumor therapy
Xinrui Wang, Meijia Lin, Liping Zhu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Xinrui Wang, Meijia Lin, Liping Zhu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Blockade of the mitochondrial DNA release ameliorates hepatic ischemia-reperfusion injury through avoiding the activation of cGAS-Sting pathway
Yi Xiong, Jiawen Chen, Wei Liang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Yi Xiong, Jiawen Chen, Wei Liang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Research Progress on Dendritic Cells in Hepatocellular Carcinoma Immune Microenvironments
Wenya Li, G Chen, Hailin Peng, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1161-1161
Open Access | Times Cited: 1
Wenya Li, G Chen, Hailin Peng, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1161-1161
Open Access | Times Cited: 1
Bidirectional regulation of the cGAS-STING pathway in the immunosuppressive tumor microenvironment and its association with immunotherapy
Yurui Zhang, Yudi Wang, Peizheng Mu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Yurui Zhang, Yudi Wang, Peizheng Mu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Advances in hyperbaric oxygen to promote immunotherapy through modulation of the tumor microenvironment
Pei Wang, Xiaoyan Wang, Changfeng Man, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Pei Wang, Xiaoyan Wang, Changfeng Man, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
The STING in Non-Alcoholic Fatty Liver Diseases: Potential Therapeutic Targets in Inflammation-Carcinogenesis Pathway
Juan Lv, Chunlei Xing, Yuhong Chen, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1241-1241
Open Access | Times Cited: 7
Juan Lv, Chunlei Xing, Yuhong Chen, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1241-1241
Open Access | Times Cited: 7
Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC
Kui-Sheng Yang, Chuanqi Xu, Jian Lv
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 1, pp. e006329-e006329
Open Access | Times Cited: 3
Kui-Sheng Yang, Chuanqi Xu, Jian Lv
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 1, pp. e006329-e006329
Open Access | Times Cited: 3
Hyperbaric Oxygen‐Facilitated Cancer Treatment: A Minireview
Zi‐Heng Li, Xinping Zhang, Fu‐Gen Wu
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 6
Open Access
Zi‐Heng Li, Xinping Zhang, Fu‐Gen Wu
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 6
Open Access
Hemoglobin nanoclusters-mediated regulation of KPNA4 in hypoxic tumor microenvironment enhances photodynamic therapy in hepatocellular carcinoma
Yiliang Wang, Nu Li, Letian Qu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access
Yiliang Wang, Nu Li, Letian Qu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access
PPARα suppresses growth of hepatocellular carcinoma in a high-fat diet context by reducing neutrophil extracellular traps release
Banglun Pan, Zhu Zhang, Dongjie Ye, et al.
JHEP Reports (2024) Vol. 7, Iss. 1, pp. 101228-101228
Open Access
Banglun Pan, Zhu Zhang, Dongjie Ye, et al.
JHEP Reports (2024) Vol. 7, Iss. 1, pp. 101228-101228
Open Access
A transformer-based deep learning survival prediction model and an explainable XGBoost anti-PD-1/PD-L1 outcome prediction model based on the cGAS-STING-centered pathways in hepatocellular carcinoma
Wang Ren, Qiumei Liu, Wenhua You, et al.
Briefings in Bioinformatics (2024) Vol. 26, Iss. 1
Open Access
Wang Ren, Qiumei Liu, Wenhua You, et al.
Briefings in Bioinformatics (2024) Vol. 26, Iss. 1
Open Access